MGMT in glial carcinogenesis. Roles from prevention to treatment

İlhan Elmaci1, Meric A Altinoz2, Eylem Burcu Kahraman Ozlu3

  • 1Department of Neurosurgery, Liv Hospital.

Insights

Investigating the O-6-methylguanine-DNA-methyltransferase (MGMT) enzyme

Area of Science:

  • Neuroscience
  • Oncology
  • Biochemistry

Background:

  • The DNA repair enzyme O-6-methylguanine-DNA-methyltransferase (MGMT) and its gene methylation are extensively studied for their role in glioblastoma treatment with temozolomide.
  • However, the association between MGMT enzyme biochemistry and the development of glial tumors (gliomagenesis) remains under-researched.

Purpose of the Study:

  • To explore the understudied link between MGMT enzyme biochemistry and gliomagenesis.
  • To investigate the role of MGMT in malignancies linked to environmental carcinogens and its potential connection to glioma development.

Main Methods:

  • Literature review and analysis of existing research on MGMT, carcinogen exposure, and gliomagenesis.
  • Exploration of potential MGMT interactions with environmental factors implicated in glioma development.

Main Results:

  • MGMT is implicated in DNA repair and its activity is influenced by gene methylation, affecting temozolomide efficacy in glioblastoma.
  • Environmental factors like ionizing radiation, smoking, polycyclic aromatic hydrocarbons, and certain chemicals are linked to both MGMT-associated malignancies and gliomagenesis.
  • Direct studies on MGMT's interaction with these specific carcinogens in the context of gliomagenesis are currently limited.

Conclusions:

  • There is a need for further research into the biochemical interactions of MGMT with environmental carcinogens to understand their role in gliomagenesis.
  • Future MGMT sequencing in high-risk populations exposed to carcinogens could inform preventive strategies against gliomas.
  • MGMT polymorphisms may influence both glioma susceptibility and response to temozolomide therapy.